Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies

Clinical studies of cell-based immunotherapies have included both patient-specific (autologous) and non-patient-specific (allogeneic) approaches. Major concerns in using allogeneic immunotherapies are that the induced immune responses may be predominantly directed against the allogeneic HLA molecule...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 133(2009), 2 vom: 14. Nov., Seite 184-97
1. Verfasser:	Li, Betty (VerfasserIn)
Weitere Verfasser:	Simmons, Andrew, Du, Thomas, Lin, Carol, Moskalenko, Marina, Gonzalez-Edick, Melissa, VanRoey, Melinda, Jooss, Karin
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2009
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Journal Article Cancer Vaccines Cytokines Histocompatibility Antigens Class I OVA-8 Peptide Fragments Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1 Ovalbumin 9006-59-1